vimarsana.com

Page 13 - Cardior Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Priced for Perfection Stocks See Rally Stall: Markets Wrap

(Bloomberg) — Stock traders decided to take some chips off the table at the start of a week that will bring the Federal Reserve’s preferred inflation measure on a day when markets will be closed. Equities pulled back after a rally that drove the S&P 500 to multiple records, spurring speculation the market has…

Novo Nordisk to buy Cardior Pharma for up to $1 billion

Novo Nordisk A/S bought Cardior Pharmaceuticals for $1 billion to enhance cardiovascular treatments. Cardior s microRNA-targeting therapies aim to improve heart function, aligning with Novo s focus on diabetes and obesity history.

Novo Nordisk Buys Heart Disease Drug Maker Cardior in $1 11 Billion Deal

Novo Nordisk AS announced a deal Monday to acquire German pharmaceutical company Cardior for up to $1.11 billion, as the Danish drugmaker looks to expand its footprint in cardiovascular medicine.

Markets today: priced for perfection U S stocks see rally stall

Markets today: priced for perfection U S stocks see rally stall
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.